Cargando…
A Pseudomonas aeruginosa-Derived Particulate Vaccine Protects against P. aeruginosa Infection
Despite numerous efforts to develop an effective vaccine against Pseudomonas aeruginosa, no vaccine has yet been approved for human use. This study investigates the utility of the P. aeruginosa inherently produced polyhydroxyalkanaote (PHA) inclusions and associated host–cell proteins (HCP) as a par...
Autores principales: | Gonzaga, Zennia Jean C., Merakou, Christina, DiGiandomenico, Antonio, Priebe, Gregory P., Rehm, Bernd H. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309987/ https://www.ncbi.nlm.nih.gov/pubmed/34358220 http://dx.doi.org/10.3390/vaccines9070803 |
Ejemplares similares
-
Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice
por: Shaikh, Mohammad Omar Faruk, et al.
Publicado: (2022) -
Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice
por: Hebert, Wesley, et al.
Publicado: (2020) -
Efficacy of a Pseudomonas aeruginosa Serogroup O9 Vaccine
por: Moustafa, Dina A., et al.
Publicado: (2023) -
Pseudomonas aeruginosa Biofilms
por: Thi, Minh Tam Tran, et al.
Publicado: (2020) -
MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model
por: Le, Hoan N., et al.
Publicado: (2018)